Medical history risk factors for non-Hodgkin's lymphoma in older women

Journal of the National Cancer Institute

Volumn 89, Issue 4, 1997, Pages 314-318

  Cerhan, James R ^a   Wallace, Robert B ^a   Folsom, Aaron R ^b   Potter, John D ^c   Sellers, Thomas A ^b   Zheng, Wei ^b   Lutz, Charles T ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER INCIDENCE; CARCINOGENESIS; DIABETES MELLITUS; DRUG EXPOSURE; FAMILIAL CANCER; FEMALE; HUMAN; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; NONHODGKIN LYMPHOMA; NORMAL HUMAN; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 0031032197     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.4.314     Document Type: Article

References (38)

1. Ries LA, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK, editors. SEER cancer statistics review, 1973-1991: tables and graphs. Bethesda (MD): National Institutes of Health. National Cancer Institute; 1994 report No.: DHHS Publ No. (NIH)94-2789.
2. Holford TR, Zheng T, Mayne ST, McKay LA. Time trends of non-Hodgkin's lymphoma: are they real? What do they mean? Cancer Res 1992;52(19 Suppl):5443s-5446s.
3. Filipovich AH, Mathur A, Kamat D, Shapiro RS. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 1992;52(19 Suppl):5465s-5467s.
4. Hoover RN. Lymphoma risks in populations with altered immunity - a search for a mechanism. Cancer Res 1992;52(19 Suppl):5477s-5478s.
5. Rabkin CS, Devesa SS, Zahm SH, Gail MH. Increasing incidence of non-Hodgkin's lymphoma. Semin Hematol 1993;30:286-96.
6. Cerhan JR, Wallace RB, Folsom AR, Potter JD, Munger RG, Prineas RJ. Transfusion history and cancer risk in older women. Ann Intern Med 1993;119:8-15.
7. Folsom AR, Kaye SA, Sellers TA, Hong CP, Cerhan JR, Potter JD, et al. Body fat distribution and 5-year risk of death in older women [published erratum appears in JAMA 1993;269:1254], JAMA 1993;269:483-7.
8. Folsom AR, Kaye SA, Prineas RJ, Potter JD, Gapstur SM, Wallace RB. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 1990;131:794-803.
9. Bisgard KM, Folsom AR, Hong CP, Sellers TA. Mortality and cancer rates in nonrespondents to a prospective cohort study of older women: 5-year follow-up. Am J Epidemiol 1994;139:990-1000.
10. Breslow NE, Day NE. Statistical methods in cancer research. Vol. II - The design and analysis of cohort studies. IARC Sci Publ 1987;82:1-406.
11. Cox DR. Regression models and life tables. J R Stat Soc [B] 1972;34:187-220.
12. Folsom AR, Zhang S, Sellers TA, Zheng W, Kushi LH, Cerhan JR. Cancer incidence among women living on farms: findings from the Iowa Women's Health Study. J Occup Environ Med 1996;38:1171-6.
13. Chiu BC, Cerhan JR, Folsom AR, Sellers TA, Kushi LH, Wallace RB, et al. Diet and risk of non-Hodgkin lymphoma in older women. JAMA 1996;275:1315-21.
14. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A metaanalysis. JAMA 1995;273:1605-9.
15. Ragozzino M, Melton LJ 3d, Chu CP, Palumbo PJ. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 1982;35:13-9.
16. O'Mara BA, Byers T, Schoenfeld E. Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis 1985;38:435-41.
17. Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D, et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991;2:307-14.
18. Natazuka T, Manabe Y, Kono M, Murayama T, Matsui T, Chihara K. Association between non-insulin dependent diabetes mellitus and non-Hodgkin's lymphoma. BMJ 1994;309: 1269.
19. Ragozzino MW, Melton LJ 3d, Palumbo PJ, Chu CP. Risk of lymphoma in individuals with diabetes mellitus. J Chronic Dis 1983;36: 363-5.
20. Cartwright RA, McKinney PA, O'Brien C, Richards ID, Roberts B, Lauder I. et al. Non-Hodgkin's lymphoma: case control epidemiological study in Yorkshire. Leuk Res 1988; 12:81-8.
21. Bernstein L, Ross RK. Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County. Cancer Res 1992;52(19 Suppl):5510s-5515s.
22. Zahm SH, Blair A, Cantor KP, Fraumeni JF Jr. Non-insulin dependent diabetes mellitus and non-Hodgkin's lymphoma. Other American studies fail to confirm an association [letter], BMJ 1995;310:1009-10.
23. La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 1994;70:950-3.
24. Levine W, Dyer AR. Shekelle RB, Schoenberger JA, Stamler J. Post-load plasma glucose and cancer mortality in middle-aged men and women. 12-year follow-up findings of the Chicago Heart Association Detection Project in Industry. Am J Epidemiol 1990;131:254-62.
25. Smith GD, Egger M, Shipley MJ, Marmot MG. Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. Am J Epidemiol 1992;136:1110-4.
26. National Center for Health Statistics, Hadden WC, Harris MI. Prevalence of diagnosed diabetes, undiagnosed diabetes, and impaired glucose tolerance in adults 20-74 years of age, United States, 1976-80. Vital and Health Statistics. Washington (DC): U.S. Govt Print Off, Series 11, No. 237. 1997 report No.: DHHS Publ No. (PHS)87-1687. Public Health Service.
27. Midthjell K, Holmen J, Bjorndal A, Lund-Larsen G. Is questionnaire information valid in the study of chronic diseases such as diabetes? The Nord-Trondelag diabetes study. J Epidemiol Community Health 1992;46:537-42.
28. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
29. Moutschen MP, Scheen AJ, Lefebvre PJ. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab 1992;18:187-201.
30. Aaronson SA. Growth factors and cancer. Science 1991;254:1146-53.
31. Krans HM. Insulin, glucagon and oral hypoglycemic drugs. In: Dukes MN, editor. Meyler's side effects of drugs. 11th ed. New York: Elsevier, 1988:889-902.
32. Kahn CR, Rosenthal AS. Immunologic reactions to insulin: insulin allergy, insulin resistance, and the autoimmune insulin syndrome. Diabetes Care 1979;2:283-95.
33. Blomberg J, Moller T, Olsson H, Anderson H, Jonsson M. Cancer morbidity in blood recipients - results of a cohort study. Eur J Cancer 1993;29A:2101-5.
34. Memon A, Doll R. A search for unknown blood-borne oncogenic viruses. Int J Cancer 1994;58:366-8.
35. Brandt L, Brandt J, Olsson H, Anderson H, Moller T. Blood transfusion as a risk factor for non-Hodgkin's lymphoma. Br J Cancer 1996;73:1148-51.
36. Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med 1994;118:371-9.
37. National Diabetes Group. Diabetes in America. 2nd ed. Bethesda (MD): National Institutes of Health and National Institute of Diabetes and Digestive and Kidney Diseases; 1995 report No.: DHHS Publ No. (NIH)95-1468.
38. Surgenor DM, Schnitzer SS. The nation's blood resource: a summary report. Bethesda (MD): National Institutes of Health; 1985 report No.: DHHS Publ No. (NIH)85-2028.